The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology.

Lastly, in those 80 years or older at the time of cancer diagnosis, CV mortality exceeded cancer mortality for all nine cancer types after follow-up ranging from 1.9 years (melanoma) to 10.6 years (lung cancer). In those aged 6079 years, CV mortality exceeded cancer mortality for seven cancer types after follow-up ranging from 5 years (bladder cancer) to 17 years (lung cancer). Another population-based study on 100 000 patients with 9 different types of cancer from England investigated the risk of CV death.[10] In patients who were diagnosed with cancer below the age of 60 years, cancer mortality generally exceeded CV mortality except for uterine cancer, for which CV and cancer mortality were similar by 11 years of follow-up. [Extracted from the article]